Drug Trial Radar · NCT06541847
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Last checked: Nov 19, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
25
Planned (sponsor's estimate)
Start
Feb 10, 2025
Primary completion
Jun 2027
Study completion Jan 2028
Sponsor
- Lead sponsor
- Healx LimitedIndustry
- Sponsor type
- Industry
- First posted
- Aug 7, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The trial will be an open label, single arm, phase 2 study to assess the tolerability and efficacy of HLX-1502 in participants with NF1 that are 16 years or older in age with progressive and/or symptomatic PN. This study will also investigate the safety and efficacy of HLX-1502 in a small cohort of 12 to 15 year olds.
Conditions
- Neurofibromatosis Type 1
Interventions
HLX-1502Drug
Participants will take an oral dose three times a day (with or without food) for up to 24 cycles (a cycle is defined as 28 days).
Primary outcomes
What the sponsor says the trial is designed to measure.
- PN response rateTime frame: 12 months
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
Children's Hospital Los Angeles
Los Angeles, California · Recruiting
Stanford University
Palo Alto, California · Recruiting
Children's Hospital Colorado
Aurora, Colorado · Recruiting
Children's National Hospital
Washington D.C., District of Columbia · Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois · Recruiting
University of Chicago
Chicago, Illinois · Recruiting
Indiana University
Indianapolis, Indiana · Recruiting
Johns Hopkins Hospital
Baltimore, Maryland · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
New York University Langone Health
New York, New York · Recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio · Recruiting
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.